Stocks · Health care · Pharmaceutical Preparations

IRONWOOD PHARMACEUTICALS INC

IRWD Clue Score47
United States Fiscal year ends December CIK 0001446847 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jon R Duane
6 Mar 2024
Director
Buy
6,920
$8.70
$60.20K
Sravan Kumar Emany
4 Mar 2024
SVP, Chief Financial Officer
Buy
10,684
$9.38
$100.22K
Sravan Kumar Emany
15 Sep 2023
SVP, Chief Financial Officer
Buy
36,072
$8.32
$300.12K
Alexander J Denner
10 Mar 2021
Director
Buy indirect
75,000
$10.54
$790.50K
Alexander J Denner
8 Mar 2021
Director
Buy indirect
150,000
$10.30
$1.55M
Alexander J Denner
5 Mar 2021
Director
Buy indirect
175,000
$10.01
$1.75M
Alexander J Denner
4 Mar 2021
Director
Buy indirect
250,000
$10.00
$2.50M
Alexander J Denner
3 Mar 2021
Director
Buy indirect
350,000
$10.02
$3.51M
Alexander J Denner
2 Mar 2021
Director
Buy indirect
500,000
$9.56
$4.78M
Alexander J Denner
1 Mar 2021
Director
Buy indirect
344,900
$9.60
$3.31M
Edward P Owens
26 Feb 2021
Director
Buy
3,000
$8.90
$26.70K
Alexander J Denner
26 Feb 2021
Director
Buy indirect
505,100
$9.20
$4.65M
Edward P Owens
25 Feb 2021
Director
Buy
5,000
$9.11
$45.55K
Edward P Owens
24 Feb 2021
Director
Buy
7,000
$9.26
$64.82K
Showing 250 of 315 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 454
Amendments (4/A) skipped 0
Filings about a different issuer 1
Unreadable filings 0
Joint filings 26
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 32
Sales at will 259
Transactions with no price 0
Shares from compensation/vesting 25,980,489
Sales filed before the plan box existed 210
History held since 4 Feb 2010